These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 24747443

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Powder, capsule and device: An imperative ménage à trois for respirable dry powders.
    Schoubben A, Blasi P, Giontella A, Giovagnoli S, Ricci M.
    Int J Pharm; 2015 Oct 15; 494(1):40-8. PubMed ID: 26255220
    [Abstract] [Full Text] [Related]

  • 5. Preparation and in vivo evaluation of a dry powder for inhalation of capreomycin.
    Fiegel J, Garcia-Contreras L, Thomas M, VerBerkmoes J, Elbert K, Hickey A, Edwards D.
    Pharm Res; 2008 Apr 15; 25(4):805-11. PubMed ID: 17657592
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.
    Minne A, Boireau H, Horta MJ, Vanbever R.
    Eur J Pharm Biopharm; 2008 Nov 15; 70(3):839-44. PubMed ID: 18620052
    [Abstract] [Full Text] [Related]

  • 8. Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery.
    Giovagnoli S, Blasi P, Schoubben A, Rossi C, Ricci M.
    Int J Pharm; 2007 Mar 21; 333(1-2):103-11. PubMed ID: 17079101
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A novel dry powder inhalable formulation incorporating three first-line anti-tubercular antibiotics.
    Chan JG, Chan HK, Prestidge CA, Denman JA, Young PM, Traini D.
    Eur J Pharm Biopharm; 2013 Feb 21; 83(2):285-92. PubMed ID: 22982733
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance.
    Bosquillon C, Lombry C, Préat V, Vanbever R.
    J Control Release; 2001 Feb 23; 70(3):329-39. PubMed ID: 11182203
    [Abstract] [Full Text] [Related]

  • 15. Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate.
    Thi TH, Danède F, Descamps M, Flament MP.
    Eur J Pharm Biopharm; 2008 Sep 23; 70(1):380-8. PubMed ID: 18504120
    [Abstract] [Full Text] [Related]

  • 16. Preparation and characterization of spray-dried powders intended for pulmonary delivery of insulin with regard to the selection of excipients.
    Razavi Rohani SS, Abnous K, Tafaghodi M.
    Int J Pharm; 2014 Apr 25; 465(1-2):464-78. PubMed ID: 24560646
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Physicochemical characterization and water vapor sorption of organic solution advanced spray-dried inhalable trehalose microparticles and nanoparticles for targeted dry powder pulmonary inhalation delivery.
    Li X, Mansour HM.
    AAPS PharmSciTech; 2011 Dec 25; 12(4):1420-30. PubMed ID: 22038473
    [Abstract] [Full Text] [Related]

  • 20. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method.
    You Y, Zhao M, Liu G, Tang X.
    J Pharm Pharmacol; 2007 Jul 25; 59(7):927-34. PubMed ID: 17637186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.